About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [170 citations: 101–169 of 169 articles]

Articles published in Chemotherapy Research and Practice have been cited 170 times. The following is a list of the 169 articles that have cited the articles published in Chemotherapy Research and Practice.

  • Rafael Paletta-Silva, Nathália Rocco-Machado, and José Meyer-Fernandes, “NADPH Oxidase Biology and the Regulation of Tyrosine Kinase Receptor Signaling and Cancer Drug Cytotoxicity,” International Journal of Molecular Sciences, vol. 14, no. 2, pp. 3683–3704, 2013. View at Publisher · View at Google Scholar
  • Wenbin Lin, Demin Liu, and Chunbai He, “Application of liposomal technologies for delivery of platinum analogs in o ncology,” International Journal Of Nanomedicine, vol. 8, pp. 3309–3319, 2013. View at Publisher · View at Google Scholar
  • S. E. Salem, E. Dahdouh, and Z. Daoud, “Resistance of Gram-Negative Bacilli in Lebanon,” ISRN Infectious Diseases, vol. 2013, pp. 1–6, 2013. View at Publisher · View at Google Scholar
  • V. Patil, V. Noronha, A. Joshi, Vamshi Muddu Krishna, S. Juvekar, Gauri Pantvaidya, Pankaj Chaturvedi, D. Chaukar, Supreeta Arya, Aswari Patil, B. Bhosale, A. Dongre, A. K. Dcruz, and K. Prabhash, “Is There a Limitation of RECIST Criteria in Prediction of Pathological Response, in Head and Neck Cancers, to Postinduction Chemotherapy?,” ISRN Oncology, vol. 2013, pp. 1–6, 2013. View at Publisher · View at Google Scholar
  • Kentaro Tamaki, Nobumitsu Tamaki, Yoshihiko Kamada, Kano Uehara, Hisamitsu Zaha, Mai Onomura, Masanori Gushimiyagi, Kaname Kurashita, Keiko Miyazato, Hiromu Tengan, Kyuichiro Miyara, and Takanori Ishida, “The Challenge to Reduce Breast Cancer Mortality in Okinawa: Consensus of th e First Okinawa Breast Oncology Meeting,” Japanese Journal of Clinical Oncology, vol. 43, no. 2, pp. 208–213, 2013. View at Publisher · View at Google Scholar
  • Alejandro Bravo-Cuellar, Georgina Hernandez-Flores, Jorge Ramiro Dominguez-Rodriguez, Paulina Gomez-Lomeli, Luis F. Jave-Suarez, Ruth De Celis-Carrillo, Adriana Aguilar-Lemarroy, and Jose Manuel Lerma-Diaz, “Pentoxifylline and the proteasome inhibitor MG132 induce apoptosis in human leukemia U937 cells through a decrease in the expression of Bcl-2 and Bcl- XL and phosphorylation of p65,” Journal Of Biomedical Science, vol. 20, 2013. View at Publisher · View at Google Scholar
  • Nadereh Behtash, Fatemeh Gaemmaghami, Elahe Rezayof, Mitra M. Gillani, and Azam Sadat Moosavi, “The WHO score predicts treatment outcome in low risk gestational trophoblas tic neoplasia patients treated with weekly intramuscular methotrexate,” Journal Of Cancer Research And Therapeutics, vol. 9, no. 1, pp. 38–43, 2013. View at Publisher · View at Google Scholar
  • Hong-Quan Duong, Young Bin Hong, Jung Soon Kim, Hee-Seok Lee, Yong Weon Yi, Yeon Jeong Kim, Antai Wang, Wenjing Zhao, Chi Heum Cho, and Yeon-Sun Seong, “Inhibition of checkpoint kinase 2 (CHK2) enhances sensitivity of pancreatic adenocarcinoma cells to gemcitabine,” Journal of Cellular and Molecular Medicine, vol. 17, no. 10, pp. 1261–1270, 2013. View at Publisher · View at Google Scholar
  • Hsin-Ling Yang, Kai-Yuan Lin, Ying-Chen Juan, K.J. Senthil Kumar, Tzong-Der Way, Pei-Chun Shen, Ssu-Ching Chen, and You-Cheng Hseu, “The anti-cancer activity of Antrodia camphorata against human ovarian carcinoma (SKOV-3) cells via modulation of HER-2/neu signaling pathway,” Journal of Ethnopharmacology, vol. 148, no. 1, pp. 254–265, 2013. View at Publisher · View at Google Scholar
  • Marina Elli, Stefania Arioli, Simone Guglielmetti, and Diego Mora, “Biocide susceptibility in bifidobacteria of human origin,” Journal of Global Antimicrobial Resistance, 2013. View at Publisher · View at Google Scholar
  • Tiangui Huang, Michael Karsy, Jian Zhuge, Minghao Zhong, and Delong Liu, “B-Raf and the inhibitors: from bench to bedside,” Journal of Hematology & Oncology, vol. 6, 2013. View at Publisher · View at Google Scholar
  • Julius Steffen, and Jan Steffen, “Driving Forces Behind the Past and Future Emergence of Personalized Medicine,” Journal of Personalized Medicine, vol. 3, no. 1, pp. 14–22, 2013. View at Publisher · View at Google Scholar
  • Shashi Rajput, B. N. Prashanth Kumar, Kaushik Kumar Dey, Ipsita Pal, and Aditya Parekh, “Molecular targeting of Akt by thymoquinone promotes G(1) arrest through tra nslation inhibition of cyclin D1 and induces apoptosis in breast cancer cel ls,” Life Sciences, vol. 93, no. 21, pp. 783–790, 2013. View at Publisher · View at Google Scholar
  • Suzanne E. Dahlberg, Joan H. Schiller, and David H. Johnson, “Does histology predict survival of advanced non-small cell lung cancer pati ents treated with platin-based chemotherapy? An analysis of the Eastern Coo perative Oncology Group Study E1594,” Lung Cancer, vol. 81, no. 1, pp. 47–52, 2013. View at Publisher · View at Google Scholar
  • Varune R. Ramnarine, Stephen Lam, and Wan L. Lam, “Genetic alterations defining NSCLC subtypes and their therapeutic implicati ons,” Lung Cancer, vol. 82, no. 2, pp. 179–189, 2013. View at Publisher · View at Google Scholar
  • Chi-Chao Liu, Pascal Leclair, and Shyong Quin Yap, “The Membrane-Proximal KXGFFKR Motif of alpha-Integrin Mediates Chemoresista nce,” Molecular and Cellular Biology, vol. 33, no. 21, pp. 4334–4345, 2013. View at Publisher · View at Google Scholar
  • Curtis R. Pickering, David M. Neskey, Mei Zhao, Marcus Vinicius Ortega Alves, Alison L. Fitzgerald, Jeffrey N. Myers, Mayur A. Gadhikar, Maria Rita Sciuto, and Abdullah A. Osman, “Chk1/2 Inhibition Overcomes the Cisplatin Resistance of Head and Neck Cance r Cells Secondary to the Loss of Functional p53,” Molecular Cancer Therapeutics, vol. 12, no. 9, pp. 1860–1873, 2013. View at Publisher · View at Google Scholar
  • Anjali Singh, Xueqing Lun, Aarthi Jayanthan, Halah Obaid, Yibing Ruan, Douglas Strother, Susan N. Chi, Amy Smith, Peter Forsyth, and Aru Narendran, “Profiling pathway-specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors (CNS ATRT): Favorable activity of targeting EGFR- ErbB2 signaling with lapatinib,” Molecular Oncology, vol. 7, no. 3, pp. 497–512, 2013. View at Publisher · View at Google Scholar
  • Natalia V. Nukolova, Hardeep S. Oberoi, Yi Zhao, Vladimir P. Chekhonin, and Tatiana K. Bronich, “LHRH-Targeted Nanogels as a Delivery System for Cisplatin to Ovarian Cancer,” Molecular Pharmaceutics, vol. 10, no. 10, pp. 3913–3921, 2013. View at Publisher · View at Google Scholar
  • Pranali P Deshpande, Swati Biswas, and Vladimir P Torchilin, “Current trends in the use of liposomes for tumor targeting,” Nanomedicine, vol. 8, no. 9, pp. 1509–1528, 2013. View at Publisher · View at Google Scholar
  • Yong Wang, Baoyan Liu, Dezhi Xu, Haitao Zhao, Yufang Zhu, and Jun Xu, “Phase II trial of temozolomide plus concurrent whole-brain radiation follow ed by TNV regimen as adjuvant therapy for patients with newly diagnosed pri mary CNS lymphoma,” Neurology India, vol. 61, no. 3, pp. 260–264, 2013. View at Publisher · View at Google Scholar
  • Giada Santin, Valeria M. Piccolini, Sergio Barni, Paola Veneroni, Vincenzo Giansanti, Veronica Dal Bo, Graziella Bernocchi, and Maria Grazia Bottone, “Mitochondrial fusion: A mechanism of cisplatin-induced resistance in neuroblastoma cells?,” NeuroToxicology, vol. 34, pp. 51–60, 2013. View at Publisher · View at Google Scholar
  • Pin Guo, Jin Lan, Jianwei Ge, and Qing Mao, “ID1 regulates U87 human cell proliferation and invasion,” Oncology Letters, vol. 6, no. 4, pp. 921–926, 2013. View at Publisher · View at Google Scholar
  • Abiodun Falodun, Nadja Engel, Udo Kragl, Barbara Nebe, and Peter Langer, “Novel anticancer alkene lactone from Persea americana,” Pharmaceutical Biology, vol. 51, no. 6, pp. 700–706, 2013. View at Publisher · View at Google Scholar
  • Yasuhito Onodera, and Jin-Min Nam, “Intracellular trafficking of integrins in cancer cells,” Pharmacology & Therapeutics, vol. 140, no. 1, pp. 1–9, 2013. View at Publisher · View at Google Scholar
  • Lu Jiang, Ting Lan, Yongchang Chen, Jianrong Sang, Yueying Li, Min Wu, Yan Tao, Ying Wang, Hai Qian, and Luo Gu, “PKG II Inhibits EGF/EGFR-Induced Migration of Gastric Cancer Cells,” Plos One, vol. 8, no. 4, 2013. View at Publisher · View at Google Scholar
  • Yan Xu, Lu Tie, Yan Pan, Qiang Geng, Shengjun Fan, Zhenyu Pan, Xin Li, Yefan Wang, and Yu An, “Layered Signaling Regulatory Networks Analysis of Gene Expression Involved in Malignant Tumorigenesis of Non-Resolving Ulcerative Colitis via Integrat ion of Cross-Study Microarray Profiles,” Plos One, vol. 8, no. 6, 2013. View at Publisher · View at Google Scholar
  • Atul A. Bharde, Raghavendra Palankar, Cornelia Fritsch, Arjen Klaver, Johannes S. Kanger, and Thomas M. Jovin, “Magnetic Nanoparticles as Mediators of Ligand-Free Activation of EGFR Signa ling,” Plos One, vol. 8, no. 7, 2013. View at Publisher · View at Google Scholar
  • Madhuri Singh, Ravisekhar Gadepalli, and Benu Dhawan, “Combination of Alpha-Melanocyte Stimulating Hormone with Conventional Antib iotics against Methicillin Resistant Staphylococcus aureus,” Plos One, vol. 8, no. 9, 2013. View at Publisher · View at Google Scholar
  • Shuang Li, Ting Hu, Yile Chen, Hang Zhou, Xiong Li, Xiaodong Cheng, Ru Yang, Xing Xie, and Ding Ma, “Adjuvant Chemotherapy, a Valuable Alternative Option in Selected Patients w ith Cervical Cancer,” Plos One, vol. 8, no. 9, 2013. View at Publisher · View at Google Scholar
  • Fiona Fouhy, Mary O'Connell Motherway, Gerald F. Fitzgerald, R. Paul Ross, Catherine Stanton, and Douwe van Sinderen, “In Silico Assigned Resistance Genes Confer Bifidobacterium with Partial Res istance to Aminoglycosides but Not to B-Lactams,” Plos One, vol. 8, no. 12, 2013. View at Publisher · View at Google Scholar
  • Lawrence J. Tartaglia, Antonette Bennett, Alexander S. Plattner, Nicholas Muzyczka, Chen Ling, and Arun Srivastava, “Molecular cloning, overexpression, and an efficient one-step purification o f alpha 5 beta 1 integrin,” Protein Expression and Purification, vol. 92, no. 1, pp. 21–28, 2013. View at Publisher · View at Google Scholar
  • Min Jueng Kang, Hwang-Phill Kim, Kyeong-seob Lee, Young-Dong Yoo, Yong-Tae Kwon, Kristine M. Kim, Tae-You Kim, and Eugene C. Yi, “Proteomic analysis reveals that CD147/EMMPRIN confers chemoresistance in ca ncer stem cell-like cells,” Proteomics, vol. 13, no. 10-11, pp. 1714–1725, 2013. View at Publisher · View at Google Scholar
  • Maria Paola Ruggieri, Maria Galeandro, Nunziata D'Abbiero, Alessandro Giunta, and Cinzia Iotti, “Short-course preoperative radiotherapy combined with chemotherapy in resect able locally advanced rectal cancer: local control and quality of life,” Radiologia Medica, vol. 118, no. 8, pp. 1397–1411, 2013. View at Publisher · View at Google Scholar
  • Neeraj Lalwani, and Christine O. Menias, “Gestational Trophoblastic Disease,” Radiologic Clinics of North America, vol. 51, no. 6, pp. 1023–+, 2013. View at Publisher · View at Google Scholar
  • Stephanie Hehlgans, Katja Storch, and Inga Lange, “The novel HDAC inhibitor NDACI054 sensitizes human cancer cells to radiothe rapy,” Radiotherapy and Oncology, vol. 109, no. 1, pp. 126–132, 2013. View at Publisher · View at Google Scholar
  • Alejandro Barrera E, Felipe Illanes F, Claudio Vargas N, and Carlos Melo L, “Prognostic value of pathological response to chemo radiotherapy of locally advanced low rectal cancer,” Revista Chilena De Cirugia, vol. 65, no. 3, pp. 236–241, 2013. View at Publisher · View at Google Scholar
  • Vicente Micol, Alejandro Vazquez-Martin, Elisabet Cuyas, Antonio Segura-Carretero, Rosa Bonavia, Bruna Corominas-Faja, Silvia Cufi, Javier A. Menendez, Cristina Oliveras-Ferraros, Jorge Joven, Begona Martin-Castillo, Enrique Barrajon-Catalan, and Joana Visa, “Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo,” Scientific Reports, vol. 3, pp. 1–10, 2013. View at Publisher · View at Google Scholar
  • Alejandro Vazquez-Martin, Silvia Cufi, Cristina Oliveras-Ferraros, Violeta Zenobia Torres-Garcia, Bruna Corominas-Faja, Elisabet Cuyas, Rosa Bonavia, Joana Visa, Begona Martin-Castillo, Enrique Barrajon-Catalan, Vicente Micol, and Joaquim Bosch-Barrera, “IGF-1R/epithelial-to-mesenchymal transition (EMT) crosstalk suppresses the erlotinib-sensitizing effect of EGFR exon 19 deletion mutations,” Scientific Reports, vol. 3, 2013. View at Publisher · View at Google Scholar
  • Thordur Oskarsson, “Extracellular matrix components in breast cancer progression and metastasis,” The Breast, vol. 22, pp. S66–S72, 2013. View at Publisher · View at Google Scholar
  • Matilde Cescon, and Paolo Bonaldo, “Collagen VI in cancer and its biological mechanisms,” Trends In Molecular Medicine, vol. 19, no. 7, pp. 410–417, 2013. View at Publisher · View at Google Scholar
  • Kazuhiro Takahashi, Ken Saito, Nobuhiro Ohkohchi, and Katsu Hirayama, “Complete response to multidisciplinary therapy in a patient with primary ga stric choriocarcinoma,” World Journal Of Gastroenterology, vol. 19, no. 31, pp. 5187–5194, 2013. View at Publisher · View at Google Scholar
  • Hiromitsu Maehira, Hiromichi Sonoda, Eiji Mekata, Tomoharo Yamaguchi, Tohru Miyake, Mitsuaki Ishida, and Tohru Tani, “A rare case of primary choriocarcinoma in the sigmoid colon,” World Journal of Gastroenterology, vol. 19, no. 39, pp. 6683–6688, 2013. View at Publisher · View at Google Scholar
  • Yanyun Zhu, Junlan Yang, Shunchang Jiao, and Tiefeng Ji, “Ganglioside-monosialic acid (GM1) prevents oxaliplatin-induced peripheral n eurotoxicity in patients with gastrointestinal tumors,” World Journal Of Surgical Oncology, vol. 11, 2013. View at Publisher · View at Google Scholar
  • Alima Gharout-Sait, Abdelaziz Touati, Said Benallaoua, Thomas Guillard, Lucien Brasme, Jannick Madoux, and Christophe De Champs, “CTX-M from community-acquired urinary tract infections in Algeria,” African Journal Of Microbiology Research, vol. 6, no. 25, pp. 5306–5313, 2012. View at Publisher · View at Google Scholar
  • Olga A. Koval, Alexandr S. Fomin, Vasily I. Kaledin, Dmitry V. Semenov, Miraslava O. Potapenko, Elena V. Kuligina, Valery P. Nikolin, Eugeny V. Nikitenko, and Vladimir A. Richter, “A novel pro-apoptotic effector lactaptin inhibits tumor growth in mice mode ls,” Biochimie, vol. 94, no. 12, pp. 2467–2474, 2012. View at Publisher · View at Google Scholar
  • Mohammad Rezaee, Elahe Alizadeh, Darel Hunting, and Léon Sanche, “DNA-Platinum Thin Films for Use in Chemoradiation Therapy Studies,” Bioinorganic Chemistry and Applications, vol. 2012, pp. 1–9, 2012. View at Publisher · View at Google Scholar
  • Bryan Hoang, Raymond M. Reilly, and Christine Allen, “Block Copolymer Micelles Target Auger Electron Radiotherapy to the Nucleus of HER2-Positive Breast Cancer Cells,” Biomacromolecules, vol. 13, no. 2, pp. 455–465, 2012. View at Publisher · View at Google Scholar
  • Bastian Scholz, and Rolf Marschalek, “Epigenetics and blood disorders,” British Journal of Haematology, vol. 158, no. 3, pp. 307–322, 2012. View at Publisher · View at Google Scholar
  • Matthias Kreppel, Sarah Danscheid, Martin Scheer, Jan Christoffer Lüers, Hans Theodor Eich, Joachim E. Zöller, Orlando Guntinas-Lichius, and Dirk Beutner, “Neoadjuvant Chemoradiation in Squamous Cell Carcinoma of the Maxillary Sinus: A 26-Year Experience,” Chemotherapy Research and Practice, vol. 2012, pp. 1–8, 2012. View at Publisher · View at Google Scholar
  • Rob Glynne-Jones, and Andrew Renehan, “Current Treatment of Anal Squamous Cell Carcinoma,” Hematology-Oncology Clinics of North America, vol. 26, no. 6, pp. 1315–+, 2012. View at Publisher · View at Google Scholar
  • Ezequiel Wexselblatt, Eylon Yavin, and Dan Gibson, “Cellular interactions of platinum drugs,” Inorganica Chimica Acta, vol. 393, pp. 75–83, 2012. View at Publisher · View at Google Scholar
  • Axel Dalhoff, “Global Fluoroquinolone Resistance Epidemiology and Implictions for Clinical Use,” Interdisciplinary Perspectives on Infectious Diseases, vol. 2012, pp. 1–37, 2012. View at Publisher · View at Google Scholar
  • Francis F. Arhin, Ingrid Sarmiento, Thomas R. Parr, and Gregory Moeck, “Activity of oritavancin and comparators in vitro against standard and high inocula of Staphylococcus aureus,” International Journal of Antimicrobial Agents, vol. 39, no. 2, pp. 159–162, 2012. View at Publisher · View at Google Scholar
  • Giada Santin, Luigi Scietti, Paola Veneroni, Sergio Barni, Graziella Bernocchi, and Maria Grazia Bottone, “Effects of Cisplatin in Neuroblastoma Rat Cells: Damage to Cellular Organelles,” International Journal of Cell Biology, vol. 2012, pp. 1–6, 2012. View at Publisher · View at Google Scholar
  • Shih-Chang Tsai, Wen-Wen Huang, Wei-Chien Huang, Chi-Cheng Lu, Jo-Hua Chiang, Shu-Fen Peng, Jing-Gung Chung, Yu-Hsin Lin, Yuan-Man Hsu, Sakae Amagaya, and Jai-Sing Yang, “ERK-modulated intrinsic signaling and G(2)/M phase arrest contribute to the induction of apoptotic death by allyl isothiocyanate in MDA-MB-468 human b reast adenocarcinoma cells,” International Journal of Oncology, vol. 41, no. 6, pp. 2065–2072, 2012. View at Publisher · View at Google Scholar
  • Alice Dewdney, and Sheela Rao, “Metastatic Squamous Cell Carcinoma of the Anus: Time for a Shift in the Treatment Paradigm?,” ISRN Oncology, vol. 2012, pp. 1–6, 2012. View at Publisher · View at Google Scholar
  • Pauline Byakika-Kibwika, Mohammed Lamorde, Violet Okaba-Kayom, Harriet Mayanja-Kizza, Elly Katabira, Warunee Hanpithakpong, Nadine Pakker, Thomas P. C. Dorlo, Joel Tarning, Niklas Lindegardh, Peter J. de Vries, David Back, Saye Khoo, and Concepta Merry, “Lopinavir/ritonavir significantly influences pharmacokinetic exposure of ar temether/lumefantrine in HIV-infected Ugandan adults,” Journal of Antimicrobial Chemotherapy, vol. 67, no. 5, pp. 1217–1223, 2012. View at Publisher · View at Google Scholar
  • D. C. Coraca-Huber, M. Fille, J. Hausdorfer, K. Pfaller, and M. Nogler, “Staphylococcus aureus biofilm formation and antibiotic susceptibility tests on polystyrene and metal surfaces,” Journal of Applied Microbiology, vol. 112, no. 6, pp. 1235–1243, 2012. View at Publisher · View at Google Scholar
  • Steven T. Sizemore, and Ruth A. Keri, “The Forkhead Box Transcription Factor FOXC1 Promotes Breast Cancer Invasion by Inducing Matrix Metalloprotease 7 (MMP7) Expression,” Journal of Biological Chemistry, vol. 287, no. 29, pp. 24631–24640, 2012. View at Publisher · View at Google Scholar
  • Maria Grazia Bottone, Dal Bo Veronica, Valeria Maria Piccolini, Giovanni Bottiroli, Sandra Angelica De Pascali, Francesco Paolo Fanizzi, and Graziella Bernocchi, “Developmental expression of cellular prion protein and apoptotic molecules in the rat cerebellum: Effects of platinum compounds,” Journal of Chemical Neuroanatomy, vol. 46, no. 1-2, pp. 19–29, 2012. View at Publisher · View at Google Scholar
  • Gerd Döring, Patrick Flume, Harry Heijerman, and J. Stuart Elborn, “Treatment of lung infection in patients with cystic fibrosis: Current and future strategies,” Journal of Cystic Fibrosis, vol. 11, no. 6, pp. 461–479, 2012. View at Publisher · View at Google Scholar
  • Ezequiel Wexselblatt, and Dan Gibson, “What do we know about the reduction of Pt(IV) pro-drugs?,” Journal of Inorganic Biochemistry, vol. 117, pp. 220–229, 2012. View at Publisher · View at Google Scholar
  • Ling Wang, Adam J. Mosel, Gregory G. Oakley, and Aimin Peng, “Deficient DNA Damage Signaling Leads to Chemoresistance to Cisplatin in Ora l Cancer,” Molecular Cancer Therapeutics, vol. 11, no. 11, pp. 2401–2409, 2012. View at Publisher · View at Google Scholar
  • N. Schulte, and R. -D. Hofheinz, “Anal cancer,” Onkologe, vol. 18, no. 8, pp. 699–704, 2012. View at Publisher · View at Google Scholar
  • Jia Wan, Edina Csaszar, Wei-Qiang Chen, Kongzhao Li, and Gert Lubec, “Proteins from Avastin (R) (bevacizumab) Show Tyrosine Nitrations for which the Consequences Are Completely Unclear,” Plos One, vol. 7, no. 4, 2012. View at Publisher · View at Google Scholar
  • Ellen V. Langemeijer, Erik Slinger, Sabrina de Munnik, Andreas Schreiber, David Maussang, Henry Vischer, Folkert Verkaar, Rob Leurs, Marco Siderius, and Martine J. Smit, “Constitutive beta-Catenin Signaling by the Viral Chemokine Receptor US28,” Plos One, vol. 7, no. 11, 2012. View at Publisher · View at Google Scholar
  • Mustafa Gulec, Elif Oral, Onur B. Dursun, Atakan Yucel, Ahmet Hacimuftuoglu, Fatih Akcay, and Halis Suleyman, “Mirtazapine protects against cisplatin-induced oxidative stress and DNA damage in the rat brain,” Psychiatry and Clinical Neurosciences, vol. 67, no. 1, pp. 50–58, 2012. View at Publisher · View at Google Scholar
  • Sandra Angelica De Pascali, Antonella Muscella, Santo Marsigliante, Maria Grazia Bottone, Graziella Bernocchi, and Francesco Paolo Fanizzi, “Cisplatin-related drugs for nongenomic targets: Forcing the reactivity with nucleobases,” Pure and Applied Chemistry, vol. 85, no. 2, pp. 355–364, 2012. View at Publisher · View at Google Scholar